PlainRecalls
FDA Drug Low Class III Terminated

Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99

Reported: November 14, 2018 Initiated: October 5, 2018 #D-0219-2019

Product Description

Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99

Reason for Recall

Container packaging defect.

Details

Units Affected
18,895 bottles
Distribution
Within the United States
Location
La Jolla, CA

Frequently Asked Questions

What product was recalled?
Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99. Recalled by Orexigen Therapeutics, Inc.. Units affected: 18,895 bottles.
Why was this product recalled?
Container packaging defect.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 14, 2018. Severity: Low. Recall number: D-0219-2019.